Minute Molecular Diagnostics Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $4.82M
Latest Deal Amount
  • Investors
  • 1

Minute Molecular Diagnostics General Information

Description

Developer of a molecular diagnostics device designed to provide rapid immunoassays. The company's device provides central lab precision in approximately 15 minutes, enabling medical professionals to get testing results quickly.

Contact Information

Website
www.m2dx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 1800 Sherman Avenue
  • Suite 504
  • Evanston, IL 60201
  • United States
+1 (847) 000-0000

Minute Molecular Diagnostics Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Minute Molecular Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 19-Apr-2021 $4.82M 00.000 000.00 Completed Generating Revenue
3. Early Stage VC (Series A1) 22-Nov-2019 00000 00.000 000.00 Completed Generating Revenue
2. Early Stage VC (Series AA) 13-Aug-2018 $1.09M $2.39M 00.000 Completed Startup
1. Early Stage VC (Series AA) 23-May-2017 $1.3M $1.3M 00.00 Completed Startup
To view Minute Molecular Diagnostics’s complete valuation and funding history, request access »

Minute Molecular Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000 00.000000 000 000 00 000 0.000
Series A-3 00,000 00.000000 000 000 00 000 00
Series A-2 00,000 00.000000 00 00 00 00 00
Series A-1 000,000 00.000000 00 00 00 00 0.000
Series AA-2 300,000 $0.000100 $5 $5 1x $5 12.04%
Series AA-1 700,000 $0.000100 $2.21 $2.21 1x $2.21 28.08%
To view Minute Molecular Diagnostics’s complete cap table history, request access »

Minute Molecular Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a molecular diagnostics device designed to provide rapid immunoassays. The company's device provides centra
Diagnostic Equipment
Evanston, IL
00.000
00.00 0000-00-00
00000000000 00.000

00000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptat
0000000000 000000000
Newcastle Upon Tyne, United Kingdom
00 As of 0000
000.00
0000000000 0 000.00

0000000

citation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehend
0000000000 000000000
Québec, Canada
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Minute Molecular Diagnostics Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
QuantuMDx Venture Capital-Backed Newcastle Upon Tyne, United Kingdom 00 000.00 0000000000 0 000.00
0000000 Corporate Backed or Acquired Québec, Canada 000 000000&0
00000 000000000000 Venture Capital-Backed Abingdon, United Kingdom 00 000.00 00000000000 000.00
0000-00 Formerly VC-backed Barcelona, Spain 000.00 000000&0 000.00
000000 00000000000 Venture Capital-Backed Turku, Finland 00 00.000 000000000000 00.000
You’re viewing 5 of 26 competitors. Get the full list »

Minute Molecular Diagnostics Executive Team (3)

Name Title Board Seat Contact Info
David Kelso President & Chief Executive Officer
Walter Narajowski Chief Operating Officer
Sally McFall Ph.D Chief Scientific Officer
To view Minute Molecular Diagnostics’s complete executive team members history, request access »

Minute Molecular Diagnostics Board Members (4)

Name Representing Role Since
Arthur Collins Jr. Self Board Member 000 0000
David Milligan Ph.D Self Board Member 000 0000
Jack Schuler Minute Molecular Diagnostics Board Member 000 0000
William Rutter Ph.D Self Board Member 000 0000
To view Minute Molecular Diagnostics’s complete board members history, request access »

Minute Molecular Diagnostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
To view Minute Molecular Diagnostics’s complete investors history, request access »